MATHIAS OELKE

Insider Reports History

Location
Gaithersburg, MD
Signature
/s/ John Rudy, attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by MATHIAS OELKE:

Company Role Class Num Shares Value Price $ Report Date Ownership
NexImmune, Inc. Chief Science Officer Stock Option (right to buy) 15,793 04 Apr 2023 Direct

Insider Reports Filed by MATHIAS OELKE

Symbol Company Period Transactions Value $ Form Type Role Filing Time
/report/000120919123023687-oelke-mathias-2023-04-04 NexImmune, Inc. 04 Apr 2023 17 $0 4 Chief Science Officer 06 Apr 2023, 20:41
/report/000120919122058800-oelke-mathias-2022-11-22 NexImmune, Inc. 22 Nov 2022 1 $0 4 Chief Science Officer 25 Nov 2022, 16:04
/report/000120919122023749-oelke-mathias-2022-04-05 NexImmune, Inc. 05 Apr 2022 1 $0 4 Chief Science Officer 07 Apr 2022, 19:24
/report/000120919122023744-oelke-mathias-2022-04-05 NexImmune, Inc. 05 Apr 2022 0 $0 3 Chief Science Officer 07 Apr 2022, 19:10